MCRB - Seres Therapeutics cuts 25% of workforce to extend cash runway into Q2 2026
2025-09-23 07:50:05 ET
More on Seres Therapeutics
- Seres Therapeutics, Inc. 2025 Q2 - Results - Earnings Call Presentation
- Seres Therapeutics, Inc. (MCRB) Q2 2025 Earnings Call Transcript
- Seres?Therapeutics: Speculative Gem Backed By SER?155 FDA Breakthrough
- Biggest stock movers Monday: RAPP, MCRB, SATS, QS, SMMT and more
- Seres Therapeutics soars on report of takeover offer